A noninvasive test to flag people at high risk for antidepressant-related sexual dysfunction could improve treatment ...
Founded by two neuroscientists, NeuroKaire says its novel, AI-assisted tech uses stem cells to create a brain proxy against which drugs can be tested to find the best one ...
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta ...
Based on RNA editing and artificial intelligence, the myEDIT-B test reflects an emerging focus on precision psychiatry, providing a biological tool that complements clinical diagnosis.
From mood trackers to guided cognitive-behavioral therapy (CBT) and peer support, depression apps are crowding the digital marketplace. As more patients turn to this technology to ease their symptoms, ...
Around 13,000 genetic markers linked with depression in women compared with 7,000 markers in men, reveals study ...
Psilocybin could be the future of mental health care, with promising findings emerging from Australia's first research trial ...